XML 179 R13.htm IDEA: XBRL DOCUMENT

Dispositions of Real Estate	3 Months Ended
Dispositions of Real Estate	Mar. 31, 2024
Discontinued Operations and Disposal Groups [Abstract]
Dispositions of Real Estate	Dispositions of Real Estate 2024 Dispositions of Real Estate During the three months ended March 31, 2024, the Company sold two outpatient medical buildings for $29 million, resulting in total gain on sales of $3 million. In April 2024, the Company sold a portfolio of seven lab buildings for $180 million. 2023 Dispositions of Real Estate During the three months ended March 31, 2023, the Company sold two lab buildings in Durham, North Carolina for $113 million, resulting in total gain on sales of $60 million. Also during the three months ended March 31, 2023, the Company sold two outpatient medical buildings for $32 million, resulting in total gain on sales of $21 million. Held for Sale As of March 31, 2024, no assets were classified as held for sale. As of December 31, 2023, two lab buildings and one outpatient medical building were classified as held for sale, with a carrying value of $118 million, primarily comprised of net real estate assets. As of December 31, 2023, liabilities related to the assets held for sale were $1 million. During the three months ended March 31, 2024, the Company sold the outpatient medical building and a 65% interest in the two lab buildings (see Note 8) held for sale as of December 31, 2023. Impairments of Real Estate During the three months ended March 31, 2024 and 2023, the Company did not recognize any impairment charges.